...
Richard Norman (Unlicensed) (Pistoia Alliance)
Qing Chai (Deactivated) (Eli Lilly)
- Craig Dickinson (Unlicensed) (Eli Lilly)
- Guy Georges (Unlicensed) (Roche)
- Francisco Fernandez (Deactivated) (Abvance Biotech)
- David Hargreaves (AstraZeneca)
- Helen Li (Unlicensed) (Eli Lilly)
- Kieran Todd (Deactivated) (GSK)
Discussion items
| Time | Item | Who | Notes |
|---|---|---|---|
| 15:00 - 16:00 BST (60 mins) | >What internal efforts are ongoing in this space? (please can you find out or invite a relevant person)
>Solutions and approach | Richard, All | >Agree our approach to making a difference in the developability risk prediction space. |
Minutes
Introduction – current position
...